• Something wrong with this record ?

Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms

R. Moratalla, A. Khairnar, N. Simola, N. Granado, JR. García-Montes, PF. Porceddu, Y. Tizabi, G. Costa, M. Morelli,

. 2017 ; 155 (-) : 149-170. [pub] 20151009

Language English Country England, Great Britain

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc18025404

Amphetamine-related drugs, such as 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine (METH), are popular recreational psychostimulants. Several preclinical studies have demonstrated that, besides having the potential for abuse, amphetamine-related drugs may also elicit neurotoxic and neuroinflammatory effects. The neurotoxic potentials of MDMA and METH to dopaminergic and serotonergic neurons have been clearly demonstrated in both rodents and non-human primates. This review summarizes the species-specific cellular and molecular mechanisms involved in MDMA and METH-mediated neurotoxic and neuroinflammatory effects, along with the most important behavioral changes elicited by these substances in experimental animals and humans. Emphasis is placed on the neuropsychological and neurological consequences associated with the neuronal damage. Moreover, we point out the gap in our knowledge and the need for developing appropriate therapeutic strategies to manage the neurological problems associated with amphetamine-related drug abuse.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18025404
003      
CZ-PrNML
005      
20180719092458.0
007      
ta
008      
180709s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.pneurobio.2015.09.011 $2 doi
035    __
$a (PubMed)26455459
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Moratalla, Rosario $u Instituto Cajal, Consejo Superior de Investigaciones Científicas, CSIC, Madrid, Spain; CIBERNED, ISCIII, Madrid, Spain. Electronic address: moratalla@cajal.csic.es.
245    10
$a Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms / $c R. Moratalla, A. Khairnar, N. Simola, N. Granado, JR. García-Montes, PF. Porceddu, Y. Tizabi, G. Costa, M. Morelli,
520    9_
$a Amphetamine-related drugs, such as 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine (METH), are popular recreational psychostimulants. Several preclinical studies have demonstrated that, besides having the potential for abuse, amphetamine-related drugs may also elicit neurotoxic and neuroinflammatory effects. The neurotoxic potentials of MDMA and METH to dopaminergic and serotonergic neurons have been clearly demonstrated in both rodents and non-human primates. This review summarizes the species-specific cellular and molecular mechanisms involved in MDMA and METH-mediated neurotoxic and neuroinflammatory effects, along with the most important behavioral changes elicited by these substances in experimental animals and humans. Emphasis is placed on the neuropsychological and neurological consequences associated with the neuronal damage. Moreover, we point out the gap in our knowledge and the need for developing appropriate therapeutic strategies to manage the neurological problems associated with amphetamine-related drug abuse.
650    _2
$a zvířata $7 D000818
650    _2
$a mozek $x účinky léků $7 D001921
650    _2
$a lidé $7 D006801
650    _2
$a methamfetamin $x škodlivé účinky $7 D008694
650    _2
$a N-methyl-3,4-methylendioxyamfetamin $x škodlivé účinky $7 D018817
650    _2
$a neurotoxické syndromy $x patologie $7 D020258
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Khairnar, Amit $u Applied Neuroscience Research Group, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
700    1_
$a Simola, Nicola $u Department of Biomedical Sciences, Section of Neuropsychopharmacology, University of Cagliari, Via Ospedale 72, 09124 Cagliari, Italy.
700    1_
$a Granado, Noelia $u Instituto Cajal, Consejo Superior de Investigaciones Científicas, CSIC, Madrid, Spain; CIBERNED, ISCIII, Madrid, Spain.
700    1_
$a García-Montes, Jose Ruben $u Instituto Cajal, Consejo Superior de Investigaciones Científicas, CSIC, Madrid, Spain; CIBERNED, ISCIII, Madrid, Spain.
700    1_
$a Porceddu, Pier Francesca $u Department of Biomedical Sciences, Section of Neuropsychopharmacology, University of Cagliari, Via Ospedale 72, 09124 Cagliari, Italy.
700    1_
$a Tizabi, Yousef $u Department of Pharmacology, Howard University College of Medicine, Washington, DC, USA.
700    1_
$a Costa, Giulia $u Department of Biomedical Sciences, Section of Neuropsychopharmacology, University of Cagliari, Via Ospedale 72, 09124 Cagliari, Italy.
700    1_
$a Morelli, Micaela $u Department of Biomedical Sciences, Section of Neuropsychopharmacology, University of Cagliari, Via Ospedale 72, 09124 Cagliari, Italy; Centre of Excellence for Neurobiology of Dependence, University of Cagliari, Cagliari, Italy; National Research Council (CNR), Institute of Neuroscience, Cagliari, Italy.
773    0_
$w MED00003928 $t Progress in neurobiology $x 1873-5118 $g Roč. 155, č. - (2017), s. 149-170
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26455459 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180719092759 $b ABA008
999    __
$a ok $b bmc $g 1317535 $s 1022325
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 155 $c - $d 149-170 $e 20151009 $i 1873-5118 $m Progress in neurobiology $n Prog Neurobiol $x MED00003928
LZP    __
$a Pubmed-20180709

Find record

Citation metrics

Archiving options